Publications

The potential cost-effectiveness of HPV vaccination among girls in Mongolia.

Luvsan, M-E; Vodicka, E; Jugder, U; Tudev, U; CLARK, A; Groman, D; Otgonbayar, D; Demberelsuren, S; LaMongtagne, DS; Pecenka, C;

2022

Vaccine: X, (2022).11, 10.1016/j.jvacx.2022.100161.

Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China.

SUN, L; Cui, B; WEI, X; SADIQUE, Z; Yang, L; Manchanda, R; LEGOOD, R;

2022

CANCERS, (2022).14 7 10.3390/cancers14071839.

yangclaraliu/COVID_Vac_Delay.

LIU, Y;

2022

, Github (2022).

Rethinking external assistance for health.

Shroff, ZC; Sparkes, S; Skarphedinsdottir, M; HANSON, K;

2022

Health Policy and Planning, (2022).37 7 10.1093/heapol/czac030.

Erratum: Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.

Gould, DW; Doidge, J; Sadique, MZ; Borthwick, M; Hatch, R; Caskey, FJ; Forni, L; Lawrence, RF; MacEwen, C; Ostermann, M; Mouncey, PR; Harrison, DA; Rowan, KM; Young, JD; Watkinson, PJ;

2022

Health technology assessment (Winchester, England), (2022).26 13 10.3310/zxhi9396-c202204.

Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial.

Mosha, JF; Kulkarni, MA; Lukole, E; MATOWO, NS; PITT, C; MESSENGER, LA; Mallya, E; Jumanne, M; Aziz, T; Kaaya, R; Shirima, BA; Isaya, G; Taljaard, M; MARTIN, J; Hashim, R; Thickstun, C; Manjurano, A; KLEINSCHMIDT, I; Mosha, FW; ROWLAND, M; PROTOPOPOFF, N;

2022

The Lancet, (2022).399 10331 10.1016/S0140-6736(21)02499-5.

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges.

Gomes, M; Latimer, N; Soares, M; Dias, S; Baio, G; Freemantle, N; Dawoud, D; Wailoo, A; GRIEVE, R;

2022

PharmacoEconomics, (2022).40 6 10.1007/s40273-022-01141-x.

A Scoping Review of Item-Level Missing Data in Within-Trial Cost-Effectiveness Analysis.

Ling, X; Gabrio, A; MASON, A; Baio, G;

2022

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2022).25 9 10.1016/j.jval.2022.02.009.

Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.

Ferrari, G; TORRES-RUEDA, S; Chirwa, E; Gibbs, A; Orangi, S; Barasa, E; Tawiah, T; Dwommoh Prah, RK; Hitimana, R; Daviaud, E; Kapapa, E; Dunkle, K; Heise, L; STERN, E; Chatterji, S; Omondi, B; Ogum Alangea, D; Karmaliani, R; Maqbool Ahmed Khuwaja, H; Jewkes, R; Watts, C; VASSALL, A;

2022

PLOS MEDICINE, (2022).19 3 10.1371/journal.pmed.1003827.

Developing a tool to assess the skills to perform a health technology assessment.

Bidonde, J; Meneses-Echavez, JF; Asare, B; Chola, L; Gad, M; Heupink, LF; Peacocke, EF; IDSI Ghana HTA collaboration Group,;

2022

BMC medical research methodology, (2022).22 1 10.1186/s12874-022-01562-4.